1132387

Cayman Pharma s.r.o. — FEI 3003625059

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 30, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Neratovice (Czech Republic)

Additional Details

Mutual Recognition Agreement (MRA)